Q3 2025 · 13F-HR
AJU IB Investment Co., Ltd.holdings as filed
Filed 2025-11-06 · accession 0001140361-25-040613
$115.1M
Reported value
7
Positions
2025-09-30
Period end
The Brief · AJU IB Investment Co., Ltd. · Q3 2025
AI · grounded in 13F
AJU IB Investment Co., Ltd. established a new position in ACLXGBX valued at $86.0M. The fund also initiated a new stake in KYMR for $25.9M and added SEER for $1.8M. Other new positions include XILIO THERAPEUTICS INC, RALLYBIO CORP, and RAPT THERAPEUTICS INC.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $86.0M | 74.7% | 1,047,557 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $25.9M | 22.5% | 457,059 | Common | SOLE |
| 81578P106 | SEER | SEER INC | $1.8M | 1.57% | 816,375 | Common | SOLE |
| 98422T100 | XLO | XILIO THERAPEUTICS INC | $595,559 | 0.52% | 667,742 | Common | SOLE |
| 75120L100 | RLYB | RALLYBIO CORP | $377,339 | 0.33% | 754,678 | Common | SOLE |
| 75382E109 | RAPT | RAPT THERAPEUTICS INC | $320,750 | 0.28% | 12,437 | Common | SOLE |
| 869367102 | STRO | SUTRO BIOPHARMA INC | $153,125 | 0.13% | 175,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.